Thursday, January 19, 2012

J&J Said to Settle Texas Risperdal Anti-Psychotic Drug Case - Businessweek

By Jef Feeley and Margaret Cronin Fisk

Jan. 19 (Bloomberg) -- Johnson & Johnson agreed to settle Texas officials’ claims that the drugmaker fraudulently marketed its Risperdal anti-psychotic drug and end a trial over the allegations, people familiar with the case said. The settlement will be announced in court today, the people said.

Posted via email from Jack's posterous

1 comment:

Anonymous said...

Soulful Sepulcher says it's $158 million as reported here:

It's not only the money. It's the likelihood that any agreement includes terms that there's no admission of guilt. An admission of guilt would make it easier to get settlements in other states as well as probably have other consequences.